Evidence map›Paper›PMID 35251170›Full record

ArticleJournal of oncology2022

Overexpression of PTPRZ1 Regulates p120/

Liwei Ma, Ting Shen, Hui Peng, Jianjun Wu, Wenjin Wang, Xing Gao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Functions of p120-catenin in physiology and diseases.Frontiers in molecular biosciences · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liwei MaDepartment of Oral Medicine, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China.
Ting ShenXiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, Hunan Province 410008, China.
Hui PengDepartment of Oral Medicine, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China.
Jianjun WuDepartment of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China.
Wenjin WangDepartment of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China.
Xing GaoDepartment of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China.ORCID https://orcid.org/0000-0002-9362-1089
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral submucous fibrosis (OSF) is a potentially malignant disease of the oral cavity. New molecular predictors are needed to identify the high risk of malignant transformation in potentially malignant oral lesions. Our purpose is to explore PTPRZ1 and p120/

methodsThe expression of PTPRZ1, p120, and

resultsPTPRZ1, p120, and

conclusionsOverexpression of PTPRZ1 regulated the phosphorylation of p120/

Identifiers

PMID35251170
PMCPMC8890887
OpenAlexW4213431934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.